Repertoire Partners’s Dentsply Sirona XRAY Stock Holding History

Repertoire Partners’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-36,400	Closed	-$1.3M	–	83
2022 Q2	$1.3M	Buy	+36,400	New	+$1.47M	0.43%	21

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Repertoire Partners's XRAY Position: Q4 2022 in Review

Repertoire Partners sold out of Dentsply Sirona (XRAY) in Q4 2022, closing a stake of 124,433 shares — an estimated $3.53M sold.

Repertoire Partners first reported a position in XRAY in Q1 2022 and held it in 3 quarters. The position peaked at $3.53M in Q3 2022. 436 funds tracked by Wall St. Rank hold XRAY as of Q4 2022.

Repertoire Partners reported no remaining Dentsply Sirona position as of Q4 2022 after selling out during the quarter.
Repertoire Partners sold 124,433 Dentsply Sirona shares in Q4 2022, an estimated $3.53M.
Repertoire Partners first reported a position in Dentsply Sirona in Q1 2022 and held it in 3 quarters.
Repertoire Partners's Dentsply Sirona position peaked at $3.53M in Q3 2022.
436 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2022.

Based on Repertoire Partners's 13F filing for Q4 2022, filed 14 Feb 2023.